J. R.- Consulting or Advisory Role for Elucida Oncology. Y.L.- Consulting or Advisory Role for AstraZeneca, Janssen, Lilly, Turning Point Therapeutics; Research Funding to Institution from Merck, Tolero Pharmaceuticals, Blueprint Medicines, Daiichi Sankyo, Genmab, Mirati Therapeutics, Roche/Genentech. M.S.- Honoraria from Horizon CME, Daiichi Sankyo, Deciphera, AADi; Travel, Accommodations, Expenses from Horizon CME. M.E.-Consulting or Advisory Role for WindMIL, Flame Biosciences, Sanofi/Regeneron, Kanaph Therapeutics, Coherus BioSciences, GE Healthcare, BioAtla; Travel, Accommodations, Expenses from Nektar; Research Funding to institution from Bristol-Myers Squibb, Apexigen, Nektar, GlaxoSmithKline, Windmil, United Therapeutics; Patent application for radiopharmaceutical to treat small cell lung cancer by Institution; Stock and Other Ownership Interests in Biomarker Strategies, Creatv MicroTech; Other Relationship: AstraZeneca/MedImmune, Boehringer Ingelheim, Takeda, Seagen, Anheart Therapeutics. A.K.- Consulting or Advisory Role for Bayer Health, Bristol-Myers Squibb, Merck, Exelixis, Genentech/Roche, Eisai, AstraZeneca; Research Funding to institution from Bristol-Myers Squibb, Merck, Bayer/Onyx, Genentech, Adaptimmune, Hengrui Pharmaceutical; Honoraria from Merck, Exelixis, Bayer Health, Bristol-Myers Squibb, Eisai, Genentech/Roche, AstraZeneca; Travel, Accommodations, Expenses from Exelixis, Merck, Bayer/Onyx, Bristol-Myers Squibb, Eisai, Genentech/Roche, AstraZeneca. J.P.- Consulting or Advisory Role for Lilly, Seagen. S.D.- Research Funding to institution from Bristol-Myers Squibb, Merck, Boston Scientific, Symphogen, I-Mab, TriSalus Life Sciences, Tvardi Therapeutics, EMD Serono, ORIC Pharmaceuticals; Stock and Other Ownership Interests in Johnson & Johnson/MedTech. L.R- has received grant support from ARIAD Pharmaceuticals, Bayer, BTG International, Exact Sciences, Gilead Sciences, Glycotest, RedHill, Target PharmaSolutions, and Wako Diagnostics; he has provided advisory services to Bayer, Exact Sciences, Gilead Sciences, GRAIL, QED Therapeutics, and TAVEC. G.S.- Consulting or Advisory Role to Bionaut Labs, Ellipses Pharma, Gencirq, Epizyme, Array BioPharma, Apexigen, Oncogenuity, Oncusp Therapeutics, Concarlo, Shanghai Pharma, Astex Pharmaceuticals, January Therapeutics, Sellas Life Sciences, PureTech, AADi, Kirilys Therapeutics, Agenus, Boehringer Ingelheim, Ipsen; Travel, Accommodations, Expenses from Array BioPharma, Epizyme, Boehringer Ingelheim; Patents, Royalties, Other Intellectual Property by institution Companion diagnostics for CD4 inhibitors, Patent granted to develop a new technology called PNAs for cancer therapy; Stock and Other Ownership Interests in GenCirq, Bionaut Labs, January Therapeutics; Research Funding to institution from Astex Pharmaceuticals, Incyte, Calithera Biosciences, Lilly, Daiichi Sankyo, Fortress Biotech, Karyopharm Therapeutics, Oxford BioTherapeutics, Astex Pharmaceuticals, TopAlliance BioSciences Inc, Adaptimmune, SpringWorks Therapeutics, TRACON Pharma. A.WH.- Research Funding to institution from ProLynx, Amgen; Patents, Royalties, Other Intellectual Property by institution in TORL Therapeutics; Consulting or Advisory Role for Oxcia; Speakers' Bureau for OncLive. S.K.- Consulting or Advisory Role for Attivare Therapeutics; Research Funding to Institution from Takeda; Patents, Royalties, Other Intellectual Property owned by Mayo Clinic an antibody developed in the Kaufmann laboratory; Uncompensated Relationships with ProLynx. A.A.- Consulting or Advisory Role for Janssen, EMD Serono, Zai Lab, Swiss Rockets, Mirati Therapeutics; Research Funding to institution from Bayer Schering Pharma, Tesaro, I-Mab, Kura Oncology, Merck KGaA, Zai Lab, Jacobio; Uncompensated Relationships with Merck KGaA, Zai Lab, Swiss Rockets. J.H.- reports advisory funds from Bayer, Merck, BeiGene, Incyte, Taiho; and research funding to institution from Merck, Treos Bio, Senhwa pharmaceuticals, Bayer, Incyte, TriOncology, Seattle Genetics, Hutchison MediPharma, Pionyr Immunotherapeutics, Trovogene, G1 Therapeutics, Roche, Pfizer, Cardiff Oncology, Mirati Therapeutics, Xilis Inc. B.C.- Research Funding to institution from GlaxoSmithKline/Novartis; Speakers' Bureau for Clinical Care Options/NCCN.